HC Wainwright Increases Earnings Estimates for electroCore

electroCore, Inc. (NASDAQ:ECOR) – Investment analysts at HC Wainwright increased their FY2028 earnings per share (EPS) estimates for electroCore in a research report issued to clients and investors on Thursday, March 13th. HC Wainwright analyst S. Ramakanth now anticipates that the company will earn $2.25 per share for the year, up from their prior estimate of $2.24. HC Wainwright has a “Buy” rating and a $25.00 price objective on the stock. The consensus estimate for electroCore’s current full-year earnings is ($1.49) per share. HC Wainwright also issued estimates for electroCore’s FY2029 earnings at $3.07 EPS.

Separately, LADENBURG THALM/SH SH cut their price target on electroCore from $28.00 to $26.00 and set a “buy” rating for the company in a report on Thursday.

electroCore Price Performance

Shares of electroCore stock opened at $8.56 on Friday. electroCore has a 12 month low of $5.32 and a 12 month high of $19.49. The stock has a market capitalization of $56.98 million, a P/E ratio of -4.68 and a beta of 0.24. The business has a 50 day simple moving average of $15.84 and a two-hundred day simple moving average of $12.31.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Renaissance Technologies LLC grew its position in electroCore by 80.6% in the fourth quarter. Renaissance Technologies LLC now owns 131,786 shares of the company’s stock worth $2,136,000 after acquiring an additional 58,800 shares during the period. Geode Capital Management LLC grew its position in electroCore by 10.3% in the third quarter. Geode Capital Management LLC now owns 63,485 shares of the company’s stock worth $458,000 after acquiring an additional 5,951 shares during the period. HighTower Advisors LLC purchased a new position in electroCore in the third quarter worth approximately $255,000. Marshall Wace LLP acquired a new stake in shares of electroCore in the fourth quarter valued at $438,000. Finally, Jane Street Group LLC acquired a new stake in shares of electroCore in the fourth quarter valued at $278,000. 26.74% of the stock is currently owned by hedge funds and other institutional investors.

electroCore Company Profile

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.